A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how ...
Researchers are developing a greater understanding of Parkinson’s disease, the fastest growing neurodegenerative disease ...
The treatment uses a modified, harmless virus to deliver healthy genes to a patient’s cells to treat genetic diseases. Read ...
Swiss biotech AC Immune has said that its vaccine-like alpha-synuclein-targeted immunotherapy has shown promise in slowing ...
News-Medical.Net on MSN
Van Andel Institute and Cure Parkinson's extend major Parkinson's drug trial initiative
Van Andel Institute and Cure Parkinson's have renewed a funding agreement to support the International Linked Clinical Trials ...
Parkinson’s disease affects over 10 million people globally, with incidence increasing after age 60. Dopamine-producing neuron loss leads to both motor and non-motor symptoms, including tremors, sleep ...
News-Medical.Net on MSN
Rethinking dopamine’s role in movement and Parkinson’s disease
A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how ...
This story was commissioned by the River City Journalism Fund Mary Eagan, 71, stares at the body-height punching bag, her delicate hands buried in a pair of giant red boxing gloves. On this warm ...
People with restless leg syndrome may also have a higher risk for Parkinson's disease, a study from the Republic of Korea has ...
Jimmy Choi has proven that exercise isn’t just possible with Parkinson’s–it can also help slow the disease and improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results